ArticleThe Journal of clinical investigation2023

Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens.

Michael R Schlabach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.